[HTML][HTML] Pharmacotherapy of anxiety disorders: current and emerging treatment options
A Garakani, JW Murrough, RC Freire, RP Thom… - Frontiers in …, 2020 - frontiersin.org
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of
disability. While there continues to be expansive research in posttraumatic stress disorder …
disability. While there continues to be expansive research in posttraumatic stress disorder …
Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
A Bahji, GH Vazquez, CA Zarate Jr - Journal of affective disorders, 2021 - Elsevier
Background Ketamine appears to have a therapeutic role in certain mental disorders, most
notably depression. However, the comparative performance of different formulations of …
notably depression. However, the comparative performance of different formulations of …
Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
Abstract (R, S)-ketamine elicits rapid-acting and sustained antidepressant actions in
treatment-resistant patients with depression.(R)-ketamine produces longer-lasting …
treatment-resistant patients with depression.(R)-ketamine produces longer-lasting …
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
J Bonaventura, S Lam, M Carlton, MA Boehm… - Molecular …, 2021 - nature.com
Ketamine, a racemic mixture of (S)-ketamine and (R)-ketamine enantiomers, has been used
as an anesthetic, analgesic and more recently, as an antidepressant. However, ketamine …
as an anesthetic, analgesic and more recently, as an antidepressant. However, ketamine …
Blinding and expectancy confounds in psychedelic randomized controlled trials
SD Muthukumaraswamy, A Forsyth… - Expert review of clinical …, 2021 - Taylor & Francis
Introduction: There is increasing interest in the potential for psychedelic drugs such as
psilocybin, LSD and ketamine to treat several mental health disorders, with a growing …
psilocybin, LSD and ketamine to treat several mental health disorders, with a growing …
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Chronic stress and depressive-like behaviors in basic neuroscience research have been
associated with impairments of neuroplasticity, such as neuronal atrophy and synaptic loss …
associated with impairments of neuroplasticity, such as neuronal atrophy and synaptic loss …
Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms
Ketamine, a racemic mixture consisting of (S)-and (R)-ketamine, has been in clinical use
since 1970. Although best characterized for its dissociative anesthetic properties, ketamine …
since 1970. Although best characterized for its dissociative anesthetic properties, ketamine …
Animal models of major depression: drawbacks and challenges
Major depression is a leading contributor to the global burden of disease. This situation is
mainly related to the chronicity and/or recurrence of the disorder, and to poor response to …
mainly related to the chronicity and/or recurrence of the disorder, and to poor response to …
Mechanisms of ketamine action as an antidepressant
Clinical studies have demonstrated that a single sub-anesthetic dose of the dissociative
anesthetic ketamine induces rapid and sustained antidepressant actions. Although this …
anesthetic ketamine induces rapid and sustained antidepressant actions. Although this …
A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder
Objective: Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for
which available pharmacotherapies have limited efficacy. The authors' previous proof-of …
which available pharmacotherapies have limited efficacy. The authors' previous proof-of …